In Case You Missed It
5 Things You Must Know Before the Market Opens
Jim Cramer's Daily Booyah
Winners & Losers
The Roche drug, Ocrevus, secured FDA approval for two forms of multiple sclerosis.
Doug Kass shares his thoughts on Twitter and talks about Sears.
This little biotech packed a big wallop on Monday as its stock nearly doubled. Here's why.
Strong biotech stock has surged since November and is close to all-time highs.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.